News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Somaxon Pharmaceuticals, Inc. (SOMX) and CJ CheilJedang Announce SilenorĀ® Collaboration in South Korea


4/27/2012 10:28:35 AM

SAN DIEGO & SEOUL, South Korea--(BUSINESS WIRE)--Somaxon Pharmaceuticals, Inc. (Nasdaq: SOMX) and CJ CheilJedang Corporation today announced that they have entered into an exclusive collaboration under which CJ CheilJedang will commercialize SilenorĀ® (doxepin) for the treatment of insomnia in South Korea.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES